ZIKA VIRUS. Epic and aspects of management

Similar documents
What s Lurking out there??????

ZIKA VIRUS. John J. Russell MD May 27, 2016

Public Health Image Library. CDC/ Cynthia Goldsmith. Image #

European Centre for Disease Prevention and Control. Zika virus disease

Zika Virus: The Olympics and Beyond

Everything you ever wanted to know about Zika Virus Disease

Zika Virus. ZIKA VIRUS & PREGNANCY Stephen Champlin, M.D. FLAVIVIRIDAE VIRUS SPECTRUM. Virus family Flaviviridae

Outbreaks of Zika Virus: What Do We Know? Presented by Dr Jonathan Darbro Mosquito Control Lab, QIMR Berhgofer 15 September 2016

Epidemiology and entomology of the Zika virus outbreak

Zika Virus Basics. Flaviviridae Flavivirus Disease Vector Vaccine *Dengue (serotypes 1-4) Zika Virus Basics. Zika Virus Transmission Cycle

Zika Virus. Disclosure. Zika Virus 8/26/2016

Zika Virus. Robert Wittler, MD

Guidance for Investigation and Management of Zika Virus Infection

Zika Virus Update for Emergency Care Providers

THE ZIKA VIRUS. August 3, Sonia G. Pandit, MPH MBA Chief Executive Officer The Pandit Group

A RELOOK AT ZIKA VIRAL INFECTION AND ITS LATEST OUTBREAK IN INDIA

Zika Virus Dr Conor Doherty

Zika Virus. Maternal & Fetal Effects. John P. Elliott, MD Medical Director, Valley Perinatal Services Phoenix, Arizona

ZIKA VIRUS OUTBREAK. JANET B. EDDY M.D. KU-WICHITA PGY2 OBSTETRICS AND GYNECOLOGY RESIDENCY Dominican Republic 2016

Presentation Overview

Zika Virus Identifying an Emerging Threat. Florida Department of Health in Miami-Dade County Epidemiology, Disease Control, & Immunization Services

Objectives. Dengue, Chikungunya and Zika Virus Infection: Answers to Common Questions. Case 1. Dengue Introduction 10/15/2018

Zika Virus in the Primary Care Setting

General Description. Significance

Zika Virus Guidance for Medical Providers. Denise Smith, PHN, MPA Director of Disease Control Kern County Public Health Services Department

Zika and Emerging Infectious Diseases. Clifford T. Mauriello, MD, FAAP Assistant Clinical Professor May 31, 2016

ZIKA VIRUS. Causes, Symptoms, Treatment and Prevention

When infections go viral Zika Virus

Zika Virus Update. Partner Webinar 05/12/2016

Zika Outbreak Discussion

Zika virus: a new global threat for Dr Gina McAllister Clinical Scientist, Virology

Zika Virus. Centers for Disease Control and Prevention

Zika virus infection Interim clinical guidance for Primary Care

Zika virus: Interim guidance information for LMCs (midwives), GPs and other health professionals dealing with Zika virus in pregnancy 5 February 2016

Zika: Deet, There It Is. Anna Powell, MD Reproductive Infectious Disease Fellow THEGOS

Zika Virus. Frequently Asked Questions: Zika Virus and Pregnancy Version

Geographic distribution ZIKV

Relevant Communicable Diseases in HCT/Ps

SPECIALIZED FAMILY CARE Provider Training

Carol M. Smith, M.D., M.P.H. Commissioner of Health and Mental Health Ulster County Department of Health and Mental Health May 20, 2016

10/6/2016. Outline. Zika, Dengue, and Chikungunya Viruses in the Americas Oh My! Some Mosquito-Borne Arboviruses

Zika virus: clinical and epidemiological features

What is Zika virus (Zika)?

This memo is intended to provide information to NC clinicians and laboratories regarding diagnosis, management and reporting of Zika virus infection.

What is Zika virus? What are the symptoms and complications of Zika virus infection? Are cases expected in Canada?

ZIKA VIRUS. Annanya Gangopadhyay*, Shubhrajit Mantry, Abhinay Chhetri, Sudip das

FY 2017 President s Budget Request Overview for the National Center on Birth Defects and Developmental Disabilities

Town of Wolfeboro New Hampshire Health Notice Wolfeboro Public Health Officer Information Sheet Zika Virus

What You Need to Know ZIKA VIRUS

*This response is constantly evolving and recommendations in this presentation may change over time, please call your district epidemiologist or a

Zika Virus. Zika Virus. Priyanka Halde. 3 rd Year, MGM Institute of Health Sciences, Navi Mumbai December, 2016

Zika Virus and Prevention in Mississippi

Zika Virus. Lee Green Vector-Borne Epidemiologist Indiana State Department of Health. April 13, 2016

Updates in Infectious Diseases. Kelley Struble, DO, MS St. John Physicians Infectious Disease September 30, 2016

Module Three About Zika Virus: What is Known and Not Known

West Nile Virus. By Frank Riusech

ZIKA COLLABORATION MEETING: CLINICAL PERSPECTIVE. Julius L. Tonzel Vector-borne Diseases Epidemiologist Louisiana Office of Public Health

UPDATE ON ZIKA VIRUS INFECTION

ZIKA Virus and Mosquito Management. ACCG Rosmarie Kelly, PhD MPH 30 April 16

Zika Virus and Control Efforts in Arizona

An Introduction to Dengue, Zika and Chikungunya Viruses

Zika Virus. Division of Infectious Disease Department of Internal Medicine Global Health Program Conference Dora Lebron, MD Alexandra Stang, MD

Mercer MRC A Newsletter for and about our volunteers

Zika Virus. It may be devastating, But we might just get one step ahead of it. Learning in Retirement Winter 2017 Daniel Burnside. photo: Newsweek.

Centers for Disease Control and Prevention Zika Virus in Pregnancy What Midwives Need To Know

FIRST CONFIRMED CASE OF IMPORTED ZIKA VIRUS IN HOUSTON, TEXAS. Preventing Transmission

Yellow fever. Key facts

Zika Virus: What We Know and Don t Know Meg Fisher, MD Medical Director. Disclosures. Objectives

Zika Pregnancy and Birth Defects Surveillance

Wrapping Our Heads Around the Outbreak

Fact Sheet for Health Care Providers: Interpreting Results from the Aptima Zika Virus assay. September 7, 2016

ZIKA Jordan H. Perlow MD Banner University Medical Center Division of Maternal Fetal Medicine Phoenix Perinatal Asoociates

: AccuPower ZIKV(DENV, CHIKV) Multiplex Real-Time RT-PCR Kit. Copyright, Bioneer Corporation. All rights reserved.

Zika. Nicole Evert, MS Zoonosis Control Branch Department of State Health Services Austin, Texas

Mosquito Control Matters

Welcome All. Western Australia Oncology Menopause Endometriosis New Mothers

Vector-Borne Diseases Update: Maricopa County

Waiting in the Wings: Emergence, Impact and Control of Mosquito-Borne Viruses

Mosquitoborne Viral Diseases

Zika Virus What Every Woman Needs to Know

ZIKA: is South Africa at risk? Lucille Blumberg National Institute for Communicable Diseases South Africa

Zika Virus Outbreak & Zika Congenital Syndrome. Regional Situation and Response

Update on Transfusion- Transmitted Infectious Diseases

The problem with TORCH screening

Focus. International #57. Dengue Fever, Chikungunya and the Zika Virus. Chikungunya

CDC Responds to ZIKA Zika 101

3/29/2017. Zika in Northeast Ohio. Cuyahoga County Board of Health (CCBH)

Zika Virus: Epidemiology and Preparedness NH Emergency Preparedness Conference June 9, 2016

Mosquito Threats in LA County West Nile virus & Zika

Travel: Chikungunya, Zika,.. New worries

Mosquito Control Update. Board of County Commissioners Work Session February 16, 2016

MODULE 3: Transmission

Mosquito Threats in Burbank West Nile virus and Zika Update. Presented by Kelly Middleton, Director of Community Affairs

ZIKA PRESENTED BY DENNIS QUERTERMOUS, DIANNA HUNTER, MERCEDES RUTLEDGE, AND DRE'ANDRIA THOMPSON

The Zika Crisis: Where, What and USG/WHO? Brian R. Moyer BRMoyer & Associates, LLC Bedford, NH

Fact Sheet. Zika Virus

West Nile Fever. F. Karup Pedersen 2012

EDUCATIONAL COMMENTARY ZIKA VIRUS

Where is Yellow Fever found?

As suggested by one fellow student, please consider the CDC's "Final Rules for Control of Communicable Diseases: Interstate and Foreign

Transcription:

ZIKA VIRUS Epic and aspects of management

Classification - Belong to the family Flaviviridae which are mosquitoes borne viruses such as Dengue virus ( DEN V ), West Nile virus ( WN V ), Yellow fever Virus ( YF V ),Chicungunya virus (CHIKV ). - The name Zike is a forest in Uganda which is the main habitat of the animal reservoir ( the Macaque monkey). - Zika virus is a positive-sense single stranded RNA contained into capsid and envelope. This means that the virus can use its RNA directly as messenger RNA to start multiplication. -Polymorphism of many important genetic materials are frequent with possibility of recombination. Which is rare among other Flaviviruses. This has important impact on viral spread, zoonotic maintenance and epidemiological potential

Genetic analysis distinguishes between two distinct lineages, African and Asian, both emerged from Africa before spreading in the late 40`s to the to south east Asia and pacific islands (Polynesia ),then to the American continent. - The principal host are Macaque monkeys which live in Zika forest, Uganda.

Pathogenesis - Aedes mosquitoes family ( Egypti and Africanus species ) is implicated as vectors. -Unlike other Arboviruses, mosquitoes does not play any part in Zika virus life cycle, which means the direct transmission from patient to healthy individuals through insect bite. - The virus is inoculated into skin by carrying mosquito, facilitated by specific receptors, then spread to blood stream. -One of the characteristic s of Aedes aegypti is in door resting behavior which make it very efficient vector of Arboviruses (Dingu, Chikungunia, Zika ).

The insect habitat in bedrooms and living rooms is about 1.5 m. height. This is very important in the strategy of insect elimination using insecticide s spraying procedures. The second important route of infection is sexual transmission and genital persistence of the virus is as important as vector transmission. It was found that the time of exposure to the virus is crucial for the infection (during estrus phase,the female genitals are resistant to the virus The viral particles can persist and recovered in vaginal wash for 10 days after exposure.

Inc Severe cases with neurological complications (meningitis,meningioencephetitis, Guillan-Barre ) are not uncommon. Microcephaly in newborns of infected mother is the worst and most common manifestation of the disease. Mitosis abnormalities and Apoptotic death of human progenerator cells ( both in adults and developing nervous system in fetuses ) are frequently disrupted.

Using FISH (Fluorescence In Situ Hybridization )method analysis of chromosomes 12 and 17 showed increased frequency of abnormality ( monosomy,trisomy,polysomy )

-Incubation time is 3-7 days before symptoms appear. - Most cases are asymptomatic with mild self limiting flu like disease. - Similarity of symptoms of other Arboviruses infections confound right diagnosis.

- Rare death cases were reported in patient suffering other immunopathies ( Rheumatoid arthritis, Lupus, sickle cells, chronic corticosteroids use, alcoholism ). - The stage of pregnancy at which the mother becomes infected seems to affect the risk to the fetus. One study estimated the risk of developing microcephaly at about 1 % during the first trimester with less chance during the rest pregnancy time.

In a study on group of pregnant women developed symptoms ( rash, headache ) during pregnancy in Brazil, fetuses development was evaluated: The fetuses presented with brain lesions Amniotic fluid and tissue analysis confirmed Zika infection 27 % of newborns died within two days of life with evidence of cerebral inflammation and focal calcification. Eye Arthrogyrposis seen in few cases. Microcephaly was the prominent feature in most cases

Some cases showed head circumference within normal range although the cerebral tissue was small. This was due to Hydrocephalus symptoms in those cases

-Historically, symptomatic Zika virus infections were limited to sporadic cases or clusters of exposed humans. - Major outbreaks occurred in 2007 in Polynesia to spread later in epic proportions to Americas - Sporadic cases were reported in Europe, restricted to travelers from affected areas. This might due to the lack of vector insects.

Transmission - Viral particles can cross placenta to infect fetus in the uterine. Virus particles detected in fetus tissues from infected mothers - Possible transmission through blood products and organ transplant procedures. -Possible needle sticks injuries. Cases were reported in health workers following accidental instrumental inoculation. -Possible sexual transmission from infected males. Viral particles were detected in seminal fluids after up to 6 months and transmitted to female partner - No convincing evidence yet to support breast feeding transmission to babies although the virus was detected in milk of infected mothers. - Most reported cases of none placental transmission were coincided with contact with or exposure to mosquitoes, which cast some doubts on these routes.

Laboratory findings - Mild elevation in inflammatory markers (CRP, fibrinogen ). -Elevation in Liver enzymes,ld. CBC profile mostly normal with frequent finding of nonspecific changes (thrombocytopenia, leucopenia ) which coincide with viral infections None of these finding are diagnostic.most are found in other viruses in the family ( DENV,CHIKV )

DIAGNOSIS - Clinical diagnosis is unreliable because of symptoms overlaps with other Arboviruses. -Molecular and immunological procedures are available commercially. - Evaluation for Zika. CHIKV, DENV, should be considered concurrently for all patients with acute fever, rash, myalgia or arthralgia after travel to endemic areas. - PCR based assays are available for definitive diagnosis in large reference laboratories. - Serological assays were approved by FDA for restricted use as emergency first line procedures.

- Molecular amplification procedures (Reverse Transcriptase PCR ) are most specific and preferred approach during acute phase with viremia ( 3-7 days from onset ).Saliva samples can be processed with reliable results. Virus particles are detected in urine samples for up to 14 days after onset. The virus has been found to survive longer in urine than serum or saliva. The virus was detected in seminal fluids after 6 months of exposure.the virus can be detected in vaginal secretions for up to 10 daysa after sexual contact with infected male - The virus does not establish any latency phase in the host. -Serological tests for IgM, IgG abs are available commercially.igm abs can be detected within 3 days of onset. - Cross reactions were seen with closely related flaviviruses (DNV, WNV ) as well as vaccines to flaviviruses

Testing strategy Nucleic Acid Tests (NAT ) for patients presented with symptoms onset less than 7 days. Serology and or NAT in patients with symptoms onset more than 7 days with preference to serological procedures because viremea phase drops rapidly after 7 days. Serology tests for other flaviviruses ( DIN. CHIK. ) should be performs concurrently because of cross reactivity between them. A novel serological Elisa based procedure using None structural Protein 1 (NSP 1), to detect Abs to Zika virus with minimum crossreactivity with DIN V abs ( IgG,IgM ).

Management & Prevention 1- Mosquitoes avoidance and control: - Covering skin and exposed areas to prevent biting - Using insects repellant - Controlling breading places ( still water. Ponds ) - Using insecticides 2- Sexual transmission avoidance: - Using condoms for six months after visiting endemic areas - Avoiding pregnancy for at least six weeks after visiting endemic areas. Some studies reported detection of the virus in women after 3.5 months of symptoms.

3- Infecting mosquitoes with bacterial sp. (Wollbachia ) which make them resistant to Zika virus 4- Spreading sterile male mosquitoes 5- Spreading genetically modified strain of insects developed in Brazil (Oxitec OX513 A ) 7- Vaccination: No available successful vaccines until now. A new approach using DNA based vaccine for Fliviviruses. The DNA coding for immunogenic protein and when injected in tissues, will generates hummoral and cellular immune non specific response to the viruses. Preliminary results show that it prevent infection after exposure to the virus